BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22017545)

  • 1. Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy.
    Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Niida H; Hishida A; Yamamoto T; Kitagawa M
    Genes Cells; 2011 Nov; 16(11):1110-20. PubMed ID: 22017545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice.
    Suzuki S; Fukasawa H; Kitagawa K; Uchida C; Hattori T; Isobe T; Oda T; Misaki T; Ohashi N; Nakayama K; Nakayama KI; Hishida A; Yamamoto T; Kitagawa M
    Am J Pathol; 2007 Aug; 171(2):473-83. PubMed ID: 17620370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the Skp2/p27 axis in the progression of chronic nephropathy.
    Suzuki S; Ohashi N; Kitagawa M
    Cell Mol Life Sci; 2013 Sep; 70(18):3277-87. PubMed ID: 23255047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cells.
    Kim JY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim DH; Chae SW; Sohn JH
    World J Gastroenterol; 2014 Jan; 20(3):755-73. PubMed ID: 24574749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
    Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
    Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry.
    Yao ZP; Zhou M; Kelly SE; Seeliger MA; Robinson CV; Itzhaki LS
    J Mol Biol; 2006 Oct; 363(3):673-86. PubMed ID: 16979657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8.
    Lee EK; Kim DG; Kim JS; Yoon Y
    Cancer Res; 2011 Nov; 71(21):6827-35. PubMed ID: 21917729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
    Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
    J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
    Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
    Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1.
    Rowland RJ; Heath R; Maskell D; Thompson RF; Ranson NA; Blaza JN; Endicott JA; Noble MEM; Salamina M
    Sci Rep; 2023 Jul; 13(1):10718. PubMed ID: 37400515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three different binding sites of Cks1 are required for p27-ubiquitin ligation.
    Sitry D; Seeliger MA; Ko TK; Ganoth D; Breward SE; Itzhaki LS; Pagano M; Hershko A
    J Biol Chem; 2002 Nov; 277(44):42233-40. PubMed ID: 12140288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amelioration of renal damage in Skp2-deficient mice canceled by p27 Kip1 deficiency in Skp2-/- p27-/- mice.
    Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Liu N; Niida H; Nakayama K; Nakayama KI; Yamamoto T; Kitagawa M
    PLoS One; 2012; 7(4):e36249. PubMed ID: 22558406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.